Acquired by Axys Pharmaceuticals
Developer of high throughput analytical systems coupled with advanced bioinformatics to decipher the genetic basis of polygenic diseases.
Rockville, MD
Developer of high throughput analytical systems coupled with advanced bioinformatics to decipher the genetic basis of polygenic diseases.
Rockville, MD
Investors 1
| Date | Name | Website |
| - | New Leaf V... | nlvpartner... |
Mentions in press and media 15
| Date | Title | Description |
| 04.12.2024 | Singapore's Best Chinese Restaurant, Peach Blossoms, Elevates Chinese Cuisine with Innovative Dishes and Global Collaborations | Nestled within PARKROYAL COLLECTION Marina Bay, Singapore, Peach Blossoms concludes a year marked by sold-out chef collaborations and international accolades, including its prestigious recognition as Singapore's highest-ranked Chinese resta... |
| 21.08.2012 | Women’s health test firm raising $7.3M to understand, identify genetic markers of birth defects | Location: Foster City, Georgia. Solution/product: VitaPath’s mission is to develop DNA tests that will identify women at high risk for birth defects. Its first product is a test for certain genetic risk factors that researchers believe are ... |
| 26.06.2012 | Why this decade will be the most innovative in history | We are excited to bring Transform 2022 back in-person July 19 and virtually July 20 - 28. Join AI and data leaders for insightful talks and exciting networking opportunities. Register today! Many people believe that we’ve run out of ideas a... |
| 26.06.2012 | Why this decade will be the most innovative in history | Many people believe that we’ve run out of ideas and that the future will be one of bleak shortages of food, energy, and water. Billionaire Peter Thiel, for example, argues that, despite spectacular advances in computer-related fields, techn... |
| 11.04.2012 | Quest Diagnostics announces new CEO, gets approval for C difficile test | Philips Healthcare is the largest component of Royal Philips Electronics. Under Rusckowski’s tenure, sales in the Healthcare Division rose from $8.6 billion (€6.6 billion) in 2007 to $11.7 billion (€8.9 billion) in 2011. Last year, the comp... |
| 24.01.2012 | Quest Diagnostics seeks to grow its healthcare IT business | In a conference call with analysts, Quest Diagnostics CEO Surya N. Mohapatra said the company’s growth strategy is based on three elements, including driving innovative new tests and advancing healthcare IT services. It also wants to enhanc... |
| 18.03.2010 | Cardiac biomarker gets second life | By Mary Vanac Jake Orville always thought the cardiac inflammation biomarker developed by Dr. Stanley Hazen and his colleagues at the Cleveland Clinic was a valuable and proven technology. But his efforts to make it a commercial success for... |
| 17.03.2010 | Cleveland HeartLab: How to go to market with diagnostic test? | Based on Hazen’s research, Cleveland Clinic spin-off company PrognostiX had commercialized a test for myeloperoxidase–an enzyme that indicates inflammation in the artery walls of the heart, which can predict fatal heart attacks or strokes. ... |
| 20.09.2007 | Life sciences briefing: Thursday, Sept. 20, 2007 | Featured companies: Allergan, Athenahealth, Atria Genetics, Celera, Esprit Pharmaceuticals, Vida Diagnostics (NOTE: This item was posted on Friday, 9/21/07. I’ve backdated its timestamp to preserve the chronological order of the briefings.)... |
| 05.09.2007 | Craig Venter’s genome and our brave new world | (UPDATED: See below.) It’s finally all about him. By “him,” of course, I mean J. Craig Venter, the iconoclastic scientist who had his entire genome sequenced, posted in a public database, and analyzed in a scientific paper published Monday ... |
Show more